Mirum Pharmaceuticals (MIRM) Competitors $43.42 -0.03 (-0.07%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$43.44 +0.02 (+0.05%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MIRM vs. ROIV, LNTH, RVMD, BBIO, LEGN, TGTX, TLX, BPMC, SRPT, and AXSMShould you be buying Mirum Pharmaceuticals stock or one of its competitors? The main competitors of Mirum Pharmaceuticals include Roivant Sciences (ROIV), Lantheus (LNTH), Revolution Medicines (RVMD), BridgeBio Pharma (BBIO), Legend Biotech (LEGN), TG Therapeutics (TGTX), Telix Pharmaceuticals Limited American Depositary Shares (TLX), Blueprint Medicines (BPMC), Sarepta Therapeutics (SRPT), and Axsome Therapeutics (AXSM). These companies are all part of the "pharmaceutical products" industry. Mirum Pharmaceuticals vs. Roivant Sciences Lantheus Revolution Medicines BridgeBio Pharma Legend Biotech TG Therapeutics Telix Pharmaceuticals Limited American Depositary Shares Blueprint Medicines Sarepta Therapeutics Axsome Therapeutics Roivant Sciences (NASDAQ:ROIV) and Mirum Pharmaceuticals (NASDAQ:MIRM) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk, community ranking, media sentiment and dividends. Do institutionals and insiders hold more shares of ROIV or MIRM? 64.8% of Roivant Sciences shares are owned by institutional investors. 7.9% of Roivant Sciences shares are owned by company insiders. Comparatively, 22.9% of Mirum Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the MarketBeat Community favor ROIV or MIRM? Mirum Pharmaceuticals received 77 more outperform votes than Roivant Sciences when rated by MarketBeat users. However, 78.57% of users gave Roivant Sciences an outperform vote while only 75.86% of users gave Mirum Pharmaceuticals an outperform vote. CompanyUnderperformOutperformRoivant SciencesOutperform Votes5578.57% Underperform Votes1521.43% Mirum PharmaceuticalsOutperform Votes13275.86% Underperform Votes4224.14% Does the media favor ROIV or MIRM? In the previous week, Roivant Sciences had 3 more articles in the media than Mirum Pharmaceuticals. MarketBeat recorded 13 mentions for Roivant Sciences and 10 mentions for Mirum Pharmaceuticals. Roivant Sciences' average media sentiment score of 1.63 beat Mirum Pharmaceuticals' score of 1.45 indicating that Roivant Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Roivant Sciences 12 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Mirum Pharmaceuticals 9 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, ROIV or MIRM? Roivant Sciences has a beta of 1.25, suggesting that its share price is 25% more volatile than the S&P 500. Comparatively, Mirum Pharmaceuticals has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500. Do analysts recommend ROIV or MIRM? Roivant Sciences currently has a consensus price target of $17.50, suggesting a potential upside of 51.12%. Mirum Pharmaceuticals has a consensus price target of $58.20, suggesting a potential upside of 34.04%. Given Roivant Sciences' higher probable upside, analysts clearly believe Roivant Sciences is more favorable than Mirum Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Roivant Sciences 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00Mirum Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09 Is ROIV or MIRM more profitable? Mirum Pharmaceuticals has a net margin of -31.69% compared to Roivant Sciences' net margin of -119.54%. Roivant Sciences' return on equity of -14.05% beat Mirum Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Roivant Sciences-119.54% -14.05% -12.81% Mirum Pharmaceuticals -31.69%-41.22%-14.81% Which has higher valuation and earnings, ROIV or MIRM? Roivant Sciences has higher earnings, but lower revenue than Mirum Pharmaceuticals. Roivant Sciences is trading at a lower price-to-earnings ratio than Mirum Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRoivant Sciences$122.59M67.41$4.35B-$0.15-77.20Mirum Pharmaceuticals$336.89M6.37-$163.41M-$1.85-23.47 SummaryRoivant Sciences beats Mirum Pharmaceuticals on 11 of the 18 factors compared between the two stocks. Get Mirum Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MIRM vs. The Competition Export to ExcelMetricMirum PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.15B$6.84B$5.53B$7.93BDividend YieldN/A3.05%5.11%4.22%P/E Ratio-21.507.3222.5918.54Price / Sales6.37241.43401.35103.29Price / CashN/A65.8538.1834.62Price / Book8.156.486.774.25Net Income-$163.41M$143.41M$3.22B$248.18M7 Day Performance6.42%2.58%1.39%1.03%1 Month Performance-3.51%5.00%2.78%2.70%1 Year Performance69.61%-3.72%15.85%4.05% Mirum Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MIRMMirum Pharmaceuticals4.2422 of 5 stars$43.42-0.1%$58.20+34.0%+68.8%$2.15B$336.89M-21.50140Upcoming EarningsPositive NewsROIVRoivant Sciences2.1942 of 5 stars$10.04-1.1%$17.50+74.3%+3.3%$7.16B$122.59M-66.93860Positive NewsLNTHLantheus3.9716 of 5 stars$100.62-0.7%$129.43+28.6%+57.2%$6.89B$1.53B16.74700Upcoming EarningsPositive NewsRVMDRevolution Medicines3.7504 of 5 stars$36.56-0.5%$66.67+82.3%+4.7%$6.80B$742,000.00-10.18250Upcoming EarningsPositive NewsBBIOBridgeBio Pharma4.5565 of 5 stars$33.51-1.1%$53.00+58.2%+42.1%$6.37B$221.90M-11.76400Earnings ReportAnalyst ForecastNews CoverageLEGNLegend Biotech2.6714 of 5 stars$32.24-1.7%$79.00+145.0%-22.8%$5.92B$627.24M-33.941,070Positive NewsTGTXTG Therapeutics3.3092 of 5 stars$36.97-3.5%$40.67+10.0%+185.7%$5.81B$329.00M-369.66290Upcoming EarningsPositive NewsTLXTelix Pharmaceuticals Limited American Depositary SharesN/A$16.21-3.0%$22.00+35.7%N/A$5.48B$783.21M0.00N/AAnalyst RevisionNews CoverageGap DownBPMCBlueprint Medicines2.5415 of 5 stars$84.18-0.6%$124.95+48.4%+4.6%$5.38B$508.82M-77.94640Earnings ReportAnalyst ForecastPositive NewsSRPTSarepta Therapeutics4.745 of 5 stars$55.23+2.7%$158.70+187.3%-52.0%$5.36B$1.90B44.18840Upcoming EarningsAXSMAxsome Therapeutics4.8333 of 5 stars$103.00-1.4%$169.80+64.9%+49.9%$5.02B$385.69M-17.20380Upcoming EarningsAnalyst ForecastShort Interest ↓Positive News Related Companies and Tools Related Companies Roivant Sciences Competitors Lantheus Competitors Revolution Medicines Competitors BridgeBio Pharma Competitors Legend Biotech Competitors TG Therapeutics Competitors Telix Pharmaceuticals Limited American Depositary Shares Competitors Blueprint Medicines Competitors Sarepta Therapeutics Competitors Axsome Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MIRM) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mirum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mirum Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MIRM Stock Free MIRM Stock Alerts